Asnake Solomon, Teklehaymanot Tilahun, Hymete Ariaya, Erko Berhanu, Giday Mirutse
Medicine and Health Science College, Hawassa University, P.O. Box 1560, Hawassa, Ethiopia.
Aklilu Lemma Institute of Pathobiology, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia.
BMC Complement Altern Med. 2015 Dec 23;15:448. doi: 10.1186/s12906-015-0976-x.
The majority of the Ethiopian population is at risk of malaria largely caused by Plasmodium falciparum. The resistance of the parasite to existing drugs is the main challenge in the control of the disease and thus new therapeutic drugs are required. In Ethiopia, people use different plant species to treat malaria. However, very few of them have so far been evaluated for their safety level and antimalarial activity. Thus, the aim of this study was to evaluate the safety and antimalarial activity of extracts of Ajuga integrifolia, Clerodendrum myricoides, Melia azedarach, Peponium vogelii and Premna schimperi, locally used by the Sidama people of Ethiopia to treat malaria.
The safety level of 80 % methanol extracts of the plants were evaluated using standard acute toxicity test procedure. The antiplasmodial activity of 80 % methanol extracts of the plants were assessed in vivo using Swiss albino mice against chloroquine sensitive rodent malaria parasite, Plasmodium berghei, using the standard 4-day suppressive test procedure at doses of 200,400 and 800 mg/kg/day. The 80 % methanol extract of Ajuga integrifolia that exhibited better antimalarial activity was fractionated using different solvents and screened for its phytochemical constituents and evaluated in vivo for its antimalarial activity at doses of 100, 200 and 400 mg/kg/day.
All extracts given at the three different doses caused no lethal effect on mice in 24 h and within 10 days of observation. All extracts and fractions exhibited antimalarial activity in a dose dependant manner. The highest inhibition was exhibited by the crude extracts of A. integrifolia (35.17 %) at 800 mg/kg/day (P < 0.05). Among fractions of A. integrifolia, n-butanol fraction demonstrated the highest inhibition (29.80 %) at 400 mg/kg/day (P < 0.05). The extracts and fractions prolonged the survival time and prevented weight loss of the mice, but did not prevent PCV reduction. Phytochemical test on Ajuga integrifolia indicated the presence of alkaloids, flavonoids, saponins, terpenoids, anthraquinone, steroids, tannins, phenols and fatty acids.
Findings show that the plants are non-toxic and demonstrate antimalarial activity in a dose dependant manner suporting claims of their traditional therapeutic value for malaria treatment. However, further in-depth investigation is required to assess the potential of the plants towards the development of new antimalarial agent.
埃塞俄比亚的大多数人口面临疟疾风险,主要由恶性疟原虫引起。寄生虫对现有药物的耐药性是控制该疾病的主要挑战,因此需要新的治疗药物。在埃塞俄比亚,人们使用不同的植物种类来治疗疟疾。然而,到目前为止,其中很少有植物经过安全性水平和抗疟活性评估。因此,本研究的目的是评估埃塞俄比亚锡达马人当地用于治疗疟疾的全缘筋骨草、毛叶大青、楝树、沃氏胡椒和辛氏桢桐提取物的安全性和抗疟活性。
采用标准急性毒性试验程序评估植物80%甲醇提取物的安全性水平。采用标准的4天抑制试验程序,以200、400和800mg/kg/天的剂量,在体内使用瑞士白化小鼠针对氯喹敏感的啮齿类疟原虫伯氏疟原虫评估植物80%甲醇提取物的抗疟活性。对表现出较好抗疟活性的全缘筋骨草80%甲醇提取物用不同溶剂进行分离,筛选其植物化学成分,并以100、200和400mg/kg/天的剂量在体内评估其抗疟活性。
在三个不同剂量下给予的所有提取物在24小时内以及观察的10天内对小鼠均未产生致死作用。所有提取物和分离物均呈剂量依赖性地表现出抗疟活性。全缘筋骨草粗提物在800mg/kg/天剂量下表现出最高抑制率(35.17%)(P<0.05)。在全缘筋骨草的分离物中,正丁醇分离物在400mg/kg/天剂量下表现出最高抑制率(29.80%)(P<0.05)。提取物和分离物延长了小鼠的存活时间并防止了体重减轻,但未防止红细胞压积降低。对全缘筋骨草的植物化学测试表明存在生物碱、黄酮类化合物、皂苷、萜类化合物、蒽醌、甾体、单宁、酚类和脂肪酸。
研究结果表明这些植物无毒,并呈剂量依赖性地表现出抗疟活性,支持了它们在疟疾治疗方面的传统治疗价值。然而,需要进一步深入研究以评估这些植物在开发新型抗疟药物方面的潜力。